Microbial membrane and protein structures

Microbial membrane and protein structures represent a broad category of essential components in bacteria, fungi, and other pathogens that serve as the primary targets for antimicrobial therapy. These structures include the bacterial peptidoglycan cell wall, which provides osmotic stability, and the fungal cell membrane, characterized by the presence of ergosterol (Sarkar et al., 2023, StatPearls). Additionally, this category encompasses vital intracellular machinery such as the bacterial ribosome and enzymes like DNA gyrase, which are distinct from their human counterparts (Wilson, 2014, Cold Spring Harbor Perspectives in Biology). Drugs targeting these structures exploit these biochemical differences to achieve selective toxicity; for example, beta-lactams inhibit penicillin-binding proteins to prevent cell wall assembly, while polyenes like Amphotericin B bind to fungal ergosterol to cause membrane leakage (Nett & Andes, 2016, Infectious Disease Clinics). Because this term describes a collective group of diverse molecular entities rather than a single specific receptor or enzyme, it is considered a high-level classification in pharmacology rather than a discrete therapeutic target.

Other names

Microbial cell envelopeBacterial cell wall and membraneFungal cell wall and membraneMicrobial proteomePathogen structural components

Inhibition of cell wall synthesis, disruption of cell membrane integrity, inhibition of protein synthesis (30S or 50S ribosomal subunits), and inhibition of nucleic acid synthesis (DNA gyrase/topoisomerase).